Important NoticeThis app is for educational purposes only. You must be 18+ to use it. We do not sell any peptides on this site.

Peptide Library / Detail
Half-life
Not definitively established in humans; likely short (minutes to hours) given tripeptide structure
Delivery
Subcutaneous or intramuscular injection in research settings
Dosage
—
Research Use Only
All products listed are for laboratory research only — not for human consumption. By browsing, you acknowledge these terms.
Testagen is a short tripeptide (Lys-Glu-Asp) classified as a bioregulatory peptide that has been studied for its cellular penetration properties and potential tissue-protective effects. Research has demonstrated its ability to penetrate cell nuclei and interact with DNA, suggesting regulatory functions at the genomic level. It belongs to a class of short peptides investigated for their role in cellular signaling and homeostasis.
Research protocols typically involve administration at microgram to low milligram doses, though specific human dosing parameters remain under investigation. Studies have utilized subcutaneous or intramuscular routes in experimental models. Timing and frequency protocols vary based on research objectives, with some studies examining acute cellular effects and others investigating longer-term regulatory impacts.
Testagen demonstrates nuclear penetration capability in mammalian cells, allowing direct interaction with deoxyribooligonucleotides and DNA sequences as confirmed by fluorescence-labeled peptide studies (Fedoreyeva et al., 2011). The peptide's Lys-Glu-Asp sequence enables specific binding interactions with nucleic acids, potentially influencing gene expression and cellular regulatory pathways. Additionally, the peptide exhibits surface interaction properties that may contribute to cellular membrane dynamics and protection mechanisms.
Testagen is a short tripeptide (Lys-Glu-Asp) classified as a bioregulatory peptide that has been studied for its cellular penetration properties and potential tissue-protective effects. Research has demonstrated its ability to penetrate cell nuclei and interact with DNA, suggesting regulatory functions at the genomic level. It belongs to a class of short peptides investigated for their role in cellular signaling and homeostasis.
Testagen has an approximate half-life of Not definitively established in humans; likely short (minutes to hours) given tripeptide structure. The half-life determines how often you need to inject to maintain steady blood levels — use the Peptides Calculator half-life calculator to plot your specific dosing schedule and see the decay curve.
Testagen is typically delivered via subcutaneous or intramuscular injection in research settings. The Peptides Calculator app helps you reconstitute the vial with bacteriostatic water, calculate your exact dose in syringe units, and track each injection.
Testagen demonstrates nuclear penetration capability in mammalian cells, allowing direct interaction with deoxyribooligonucleotides and DNA sequences as confirmed by fluorescence-labeled peptide studies (Fedoreyeva et al., 2011). The peptide's Lys-Glu-Asp sequence enables specific binding interactions with nucleic acids, potentially influencing gene expression and cellular regulatory pathways. Additionally, the peptide exhibits surface interaction properties that may contribute to cellular membrane dynamics and protection mechanisms.
Studied benefits of Testagen include: Nuclear penetration allowing potential genomic-level regulation, Specific DNA and oligonucleotide binding capability, May support cellular homeostasis and regulation, Potential tissue-protective properties, Investigated for bioregulatory effects on cellular aging processes. These are research findings only — Peptides Calculator does not provide medical advice; consult a qualified healthcare professional before starting any peptide protocol.
Reported side effects of Testagen include: Limited human safety data available, Potential immunogenic responses to exogenous peptides, Injection site reactions possible with parenteral administration, Unknown long-term effects on genomic regulation, Interactions with endogenous regulatory pathways not fully characterized. Always discuss potential side effects with a licensed healthcare provider before using any research peptide.
Other recovery compounds in the Peptides Calculator library.
Half-life · Approximately 1-2 hours (estimated based on similar short peptides)
Half-life · Not extensively characterized; short peptides typically have half-lives of minutes to hours
Half-life · Approximately 30-60 minutes (varies by delivery method and formulation)
Half-life · Estimated 1-3 hours (typical for short tripeptides)
Half-life · 30-60 minutes
Half-life · Approximately 2-3 hours